Beamtree is pleased to release its audited financial results for 2024 which confirms double digit revenue growth (21%) and 129% increase in operating profit. The company also delivered cashflow breakeven in the second half of FY24.
Beamtree supports high quality sustainable health care in Australia and New Zealand and in more than 25 countries around the world with proven AI and analytic solutions which improve data quality, comparative benchmarking and decision support. We have had particular success in the last year expanding our client base in the UK, Canada and Saudi Arabia – and we have deepened our distribution partnerships with international health technology leaders including Abbott and Lean. We invested more than ever before in product innovation and are launching new software services for assisted and autonomous coding of clinical records which will transform the operating costs of hospitals and improve the quality and timeliness of data. We have also launched a new digital platform for the Health Roundtable, the world’s leading health data collaborative which brings together more than 200 hospitals in Australia and New Zealand. Our flagship AI technology – RippleDown – continues to set new standards for automation of clinical process and decision support.
Tim Kelsey, Beamtree CEO said: ‘Beamtree has had an outstanding year. I’d like to thank our board and shareholders for their support, and our customers for giving us the opportunity to serve them. Above all these results pay tribute to the world-class Beamtree team who are making such an important difference in helping to solve some of the most critical problems in modern healthcare.’
Share this article
